Similarly, serum adiponectin—a known marker of PPARγ activation—was significantly increased with pioglitazone and d‐S‐pio, while only a nonsignificant trend was seen with PXL065 (Fig. 4 B), likely because of exposure to the PPARγ‐active ( S )‐enantiomer.
← all excerpts
Deuterium-Stabilized (<i>R</i>)-Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity.
1
—
—